Peptides from the sequence of the complement factor d for medical use, especially for the treatment of ebv-associated diseases

Bailer, SusanneSusanneBailerSauer, EileenEileenSauer2024-05-212024-05-212022-07-27https://publica.fraunhofer.de/handle/publica/468567The present invention refers to peptides derived from the complement factor D and their use in the treatment or diagnosis of diseases, e.g. EBV-associated diseases.enPeptides from the sequence of the complement factor d for medical use, especially for the treatment of ebv-associated diseasesPeptide aus der Sequenz des komplementfaktors d zur medizinischen Verwendung, insbesondere zur Behandlung von EBV-assoziierten KrankheitenpatentEP4032543 A1EP20210152539